Screener / Biosimulation Software & AI Drug Design / Simulations Plus
SLP · NASDAQ
Simulations Plus
Compliant
Under AAOIFI Standard 21, Simulations Plus is compliant. Its core business is permissible and its interest-bearing debt is below 30% of market cap.
TickerSLP
ExchangeNASDAQ
SectorBiosimulation Software & AI Drug Design
Full ratios for Simulations Plus (impure revenue, debt and interest-bearing deposits under all four standards) are being added. Until then this page shows the screening verdict only. See the methodology for how each test works. Purindex publishes this screening to help people understand what they own. It does not recommend buying, selling or holding Simulations Plus or any other security.